查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786784

抗體受託製造的全球市場，規模，佔有率，趨勢，產業分析報告:各產品，來歷，各治療領域，各終端用戶，各地區 - 市場預測，2025年～2034年

Antibody Contract Manufacturing Market Size, Share, & Industry Analysis Report By Product, By Product (Monoclonal Antibodies, Polyclonal Antibodies), By Source, By Therapeutic Area, By End User, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 130 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，預計到 2034 年，抗體合約製造市場規模將達到 449.6 億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

抗體合約製造使生物製藥公司能夠透過外包單株抗體、多克隆抗體和雙特異性抗體的生產來滿足日益增長的治療和診斷需求。這些服務在嚴格的監管和品質準則下進行，以確保高產量、產品一致性和臨床級安全性。

全球癌症和其他慢性疾病的發生率不斷上升，推動了市場成長，這推動了對基於抗體的標靶治療的需求。全球腫瘤學和免疫學研發支出的不斷增長，進一步支持了下一代生物製劑的開發。

抗體合約生產市場報告重點

按產品劃分，單株抗體預計將在2024年佔最大的市場佔有率，這得益於需要長期免疫抑制治療的腎臟、肝臟和心臟移植手術數量的增加。

按來源劃分，哺乳動物抗體由於其與複雜蛋白質結構的高度相容性以及能夠產生對治療效果至關重要的糖基化譜的能力而佔市場主導地位。

依治療領域劃分，傳染病領域預計將成長最快，這得益於對抗新興病毒和慢性傳染病的抗體療法需求不斷增長。

按最終用戶劃分，預計生物製藥公司將在2024年佔絕對佔有率，這得益於將抗體生產外包給專業合約生產組織(CMO)以優化成本和快速商業化的趨勢日益增長。

2024年，北美在全球抗體合約製造市場佔主導地位，這得益於其強大的生物製藥製造能力以及先進生物製劑快速融入生產流程。

由於生物技術產業的顯著增長以及與國際製藥公司的合作和外包協議的增加，亞太地區經歷了穩步增長。

全球主要市場參與者包括龍沙集團、三星生物製品、藥明生物、勃林格殷格翰國際有限公司、富士迪奧辛斯生物技術公司、康泰倫特公司、艾伯維公司、賽默飛世爾科技公司、Shilpa Medicare 有限公司、樂天生物製品、默克集團和查爾斯河實驗室。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球抗體受託製造市場洞察

  • 市場概述
  • 抗體受託製造市場動態
    • 促進因素和機會
      • 全球癌症病例不斷增加
      • 全球研發支出不斷增加
    • 限制與課題
      • 高昂的製造成本和複雜的法規合規性
  • PESTEL分析
  • 抗體受託製造市場趨勢
  • 價值鏈分析

第5章 全球抗體受託製造市場:各產品

  • 主要調查結果
  • 簡介
  • 單株抗體
  • 多株抗體
  • 雙特異性抗體
  • 其他

第6章 全球抗體受託製造市場:來歷

  • 主要調查結果
  • 簡介
  • 哺乳類
  • 微生物

第7章 全球抗體受託製造市場:各治療領域

  • 主要調查結果
  • 簡介
  • 腫瘤學
  • 神經學
  • 心臟病
  • 感染疾病
  • 其他

第8章 全球抗體受託製造市場:各終端用戶

  • 主要調查結果
  • 簡介
  • 生物醫藥品企業
  • 研究所
  • 其他

第9章 全球抗體受託製造市場:各地區

  • 主要調查結果
  • 簡介
    • 抗體受託製造市場評估:各地區，2020-2034年
  • 北美
    • 北美:各產品，2020～2034年
    • 北美:各:來歷，2020～2034年
    • 北美:各治療領域，2020～2034年
    • 北美:各終端用戶，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各產品，2020～2034年
    • 歐洲:各來歷，2020～2034年
    • 歐洲:各治療領域，2020～2034年
    • 歐洲:各終端用戶，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各產品，2020～2034年
    • 亞太地區:各來歷，2020～2034年
    • 亞太地區:各治療領域，2020年～2034年
    • 亞太地區:各終端用戶，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各產品，2020～2034年
    • 中東·非洲:各來歷，2020～2034年
    • 中東·非洲:各治療領域，2020～2034年
    • 中東·非洲:各終端用戶，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:各產品，2020～2034年
    • 南美:各來歷，2020～2034年
    • 南美:各治療領域，2020-2034年
    • 南美:各終端用戶，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第10章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第11章 企業簡介

  • AbbVie Inc.
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • Charles River Laboratories
  • Fujifilm Diosynth Biotechnologies
  • Lonza Group AG
  • Lotte Biologics
  • Merck Group
  • Samsung Biologics
  • Shilpa Medicare Ltd.
  • Thermo Fisher Scientific Inc.
  • WuXi Biologics
Product Code: PM6086

The antibody contract manufacturing market size is expected to reach USD 44.96 billion by 2034, according to a new study by Polaris Market Research. The report "Antibody Contract Manufacturing Market Share, Size, Trends, Industry Analysis Report: By Product (Monoclonal Antibodies, Polyclonal Antibodies, Bispecific Antibodies, Others), By Source, By Therapeutic Area, By End User, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Antibody contract manufacturing involves the outsourced production of monoclonal antibodies, polyclonal, and bispecific antibodies, enabling biopharmaceutical companies to meet growing therapeutic and diagnostic demands. These services are executed under stringent regulatory and quality guidelines to ensure high yield, product consistency and clinical-grade safety.

The market growth is fueled by the increasing global incidence of cancer and other chronic diseases, which is driving demand for targeted antibody-based therapies. Rising global R&D expenditure in oncology and immunology is further boosting the development of next-generation biologics.

Antibody Contract Manufacturing Market Report Highlights

Based on product, the monoclonal antibodies segment accounted for the largest market share in 2024, due to the rising number of kidney, liver, and heart transplant surgeries requiring long-term immunosuppressive therapy.

Based on source, the mammalian segment dominated the market, driven by its high compatibility with complex protein structures and ability to produce glycosylation profiles essential for therapeutic efficacy.

Based on therapeutic area, the infectious diseases segment is expected to witness the fastest growth, fueled by increasing demand for antibody-based therapies to combat emerging viral infections and rising prevalence of chronic infectious conditions.

Based on end user, the biopharmaceutical companies segment held the dominant share in 2024, due to the growing trend of outsourcing antibody production to specialized CMOs for cost optimization and faster commercialization.

North America dominated the global antibody contract manufacturing market in 2024, fueled by robust biopharmaceutical manufacturing capacity and the rapid integration of advanced biologics into production processes.

Asia Pacific witnessed a steady growth, due to significant growth in the regional biotechnology industry, coupled with rising collaborations and outsourcing agreements with international pharmaceutical companies.

A few global key market players include Lonza Group AG, Samsung Biologics, WuXi Biologics, Boehringer Ingelheim International GmbH, Fujifilm Diosynth Biotechnologies, Catalent, Inc., AbbVie Inc., Thermo Fisher Scientific Inc., Shilpa Medicare Ltd., Lotte Biologics, Merck Group, and Charles River Laboratories.

Polaris Market Research has segmented the market report on the basis of product, source, therapeutic area, end user, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Monoclonal Antibodies

Polyclonal Antibodies

Bispecific Antibodies

Others

By Source Outlook (Revenue, USD Billion, 2020-2034)

Mammalian

Microbial

By Therapeutic Area (Revenue, USD Billion, 2020-2034)

Oncology

Neurology

Cardiology

Infectious Diseases

Other Therapeutic Areas

By End User (Revenue, USD Billion, 2020-2034)

Biopharmaceutical Companies

Research Laboratories

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Antibody Contract Manufacturing Market Insights

  • 4.1. Antibody Contract Manufacturing Market - Market Snapshot
  • 4.2. Antibody Contract Manufacturing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Cases of Cancer Worldwide
      • 4.2.1.2. Rising Global R&D Expenditure
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Manufacturing Cost and Complex Regulatory Compliance
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Antibody Contract Manufacturing Market Trends
  • 4.6. Value Chain Analysis

5. Global Antibody Contract Manufacturing Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Monoclonal Antibodies
    • 5.3.1. Global Antibody Contract Manufacturing Market, by Monoclonal Antibodies, by Region, 2020-2034 (USD Billion)
  • 5.4. Polyclonal Antibodies
    • 5.4.1. Global Antibody Contract Manufacturing Market, by Polyclonal Antibodies, by Region, 2020-2034 (USD Billion)
  • 5.5. Bispecific Antibodies
    • 5.5.1. Global Antibody Contract Manufacturing Market, by Bispecific Antibodies, by Region, 2020-2034 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Antibody Contract Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Antibody Contract Manufacturing Market, by Source

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • 6.3. Mammalian
    • 6.3.1. Global Antibody Contract Manufacturing Market, by Mammalian, by Region, 2020-2034 (USD Billion)
  • 6.4. Microbial
    • 6.4.1. Global Antibody Contract Manufacturing Market, by Microbial, by Region, 2020-2034 (USD Billion)

7. Global Antibody Contract Manufacturing Market, by Therapeutic Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 7.3. Oncology
    • 7.3.1. Global Antibody Contract Manufacturing Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 7.4. Neurology
    • 7.4.1. Global Antibody Contract Manufacturing Market, by Neurology, by Region, 2020-2034 (USD Billion)
  • 7.5. Cardiology
    • 7.5.1. Global Antibody Contract Manufacturing Market, by Cardiology, by Region, 2020-2034 (USD Billion)
  • 7.6. Infectious Diseases
    • 7.6.1. Global Antibody Contract Manufacturing Market, by Infectious Diseases, by Region, 2020-2034 (USD Billion)
  • 7.7. Other Therapeutic Areas
    • 7.7.1. Global Antibody Contract Manufacturing Market, by Other Therapeutic Areas, by Region, 2020-2034 (USD Billion)

8. Global Antibody Contract Manufacturing Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 8.3. Biopharmaceutical Companies
    • 8.3.1. Global Antibody Contract Manufacturing Market, by Biopharmaceutical Companies by Region, 2020-2034 (USD Billion)
  • 8.4. Research Laboratories
    • 8.4.1. Global Antibody Contract Manufacturing Market, by Research Laboratories, by Region, 2020-2034 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Antibody Contract Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Antibody Contract Manufacturing Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Antibody Contract Manufacturing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Antibody Contract Manufacturing Market - North America
    • 9.3.1. North America: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
    • 9.3.2. North America: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 9.3.3. North America: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.3.4. North America: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.3.5. Antibody Contract Manufacturing Market - U.S.
      • 9.3.5.1. U.S.: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.3.5.2. U.S.: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.3.5.3. U.S.: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.3.5.4. U.S.: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.3.6. Antibody Contract Manufacturing Market - Canada
      • 9.3.6.1. Canada: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 9.4. Antibody Contract Manufacturing Market - Europe
    • 9.4.1. Europe: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.5. Antibody Contract Manufacturing Market - UK
      • 9.4.5.1. UK: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.6. Antibody Contract Manufacturing Market - France
      • 9.4.6.1. France: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.7. Antibody Contract Manufacturing Market - Germany
      • 9.4.7.1. Germany: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.8. Antibody Contract Manufacturing Market - Italy
      • 9.4.8.1. Italy: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.9. Antibody Contract Manufacturing Market - Spain
      • 9.4.9.1. Spain: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.10. Antibody Contract Manufacturing Market - Netherlands
      • 9.4.10.1. Netherlands: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.11. Antibody Contract Manufacturing Market - Russia
      • 9.4.11.1. Russia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.12. Antibody Contract Manufacturing Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 9.5. Antibody Contract Manufacturing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.5. Antibody Contract Manufacturing Market - China
      • 9.5.5.1. China: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.6. Antibody Contract Manufacturing Market - India
      • 9.5.6.1. India: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.7. Antibody Contract Manufacturing Market - Malaysia
      • 9.5.7.1. Malaysia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.8. Antibody Contract Manufacturing Market - Japan
      • 9.5.8.1. Japan: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.9. Antibody Contract Manufacturing Market - Indonesia
      • 9.5.9.1. Indonesia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.10. Antibody Contract Manufacturing Market - South Korea
      • 9.5.10.1. South Korea: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.11. Antibody Contract Manufacturing Market - Australia
      • 9.5.11.1. Australia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.12. Antibody Contract Manufacturing Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 9.6. Antibody Contract Manufacturing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.6.5. Antibody Contract Manufacturing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.6.6. Antibody Contract Manufacturing Market - UAE
      • 9.6.6.1. UAE: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.6.7. Antibody Contract Manufacturing Market - Israel
      • 9.6.7.1. Israel: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.6.8. Antibody Contract Manufacturing Market - South Africa
      • 9.6.8.1. South Africa: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.6.9. Antibody Contract Manufacturing Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 9.7. Antibody Contract Manufacturing Market - Latin America
    • 9.7.1. Latin America: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.7.5. Antibody Contract Manufacturing Market - Mexico
      • 9.7.5.1. Mexico: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.7.6. Antibody Contract Manufacturing Market - Brazil
      • 9.7.6.1. Brazil: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.7.7. Antibody Contract Manufacturing Market - Argentina
      • 9.7.7.1. Argentina: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.7.8. Antibody Contract Manufacturing Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. AbbVie Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Boehringer Ingelheim International GmbH
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Catalent, Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Charles River Laboratories
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Fujifilm Diosynth Biotechnologies
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Lonza Group AG
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Lotte Biologics
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Merck Group
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Samsung Biologics
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Shilpa Medicare Ltd.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Thermo Fisher Scientific Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. WuXi Biologics
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development

List of Tables:

  • Table 1 Global Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 3 Global Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 4 Global Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 5 North America: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 6 North America: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 7 North America: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 8 North America: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 9 U.S.: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 10 U.S.: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 11 U.S.: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 12 U.S.: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 13 Canada: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 14 Canada: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 15 Canada: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 16 Canada: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 17 Europe: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 18 Europe: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 19 Europe: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 20 Europe: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 21 UK: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 22 UK: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 23 UK: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 24 UK: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 25 France: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 26 France: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 27 France: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 28 France: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 29 Germany: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 30 Germany: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 31 Germany: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 32 Germany: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 33 Italy: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 34 Italy: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 35 Italy: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 36 Italy: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 37 Spain: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Spain: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 39 Spain: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 40 Spain: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 45 Russia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 46 Russia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 47 Russia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 48 Russia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 57 China: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 58 China: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 59 China: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 60 China: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 61 India: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 62 India: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 63 India: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 64 India: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 69 Japan: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 70 Japan: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 71 Japan: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 72 Japan: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 77 South Korea: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 78 South Korea: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 79 South Korea: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 80 South Korea: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 81 Australia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 82 Australia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 83 Australia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 84 Australia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 97 UAE: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 98 UAE: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 99 UAE: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 100 UAE: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 101 Israel: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 102 Israel: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 103 Israel: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 104 Israel: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 105 South Africa: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 106 South Africa: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 107 South Africa: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 108 South Africa: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 113 Latin America: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 114 Latin America: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 115 Latin America: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 116 Latin America: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 117 Mexico: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 118 Mexico: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 119 Mexico: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 120 Mexico: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 121 Brazil: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 122 Brazil: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 123 Brazil: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 124 Brazil: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 125 Argentina: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 126 Argentina: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 127 Argentina: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 128 Argentina: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Antibody Contract Manufacturing Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Antibody Contract Manufacturing Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Source
  • Figure 9. Global Antibody Contract Manufacturing Market, by Source, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Therapeutic Area
  • Figure 11. Global Antibody Contract Manufacturing Market, by Therapeutic Area, 2024 & 2034 (USD Billion)
  • Figure 12. Market by End User
  • Figure 13. Global Antibody Contract Manufacturing Market, by End User, 2024 & 2034 (USD Billion)